[Migraine: clinical aspects, diagnosis and pharmacotherapy].
Diener
H C
HC
Klinik und Poliklinik für Neurologie, Essen. h.diener@uni-essen.de
Kaube
H
H
Limmroth
V
V
D000208:Acute Disease; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004638:Emergency Treatment; D004827:Epilepsy; D004878:Ergotamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D020022:Genetic Predisposition to Disease; D005858:Germany; D006801:Humans; D008597:Menstrual Cycle; D008881:Migraine Disorders / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology / Q000517:prevention & control; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D018712:Analgesics, Non-Narcotic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D017366:Serotonin Receptor Agonists; D014665:Vasodilator Agents; D004878:Ergotamine